Nexobrid Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The nexobrid market research report is one of a series of new reports that provides nexobrid market statistics, including the nexobrid industry global market size, regional shares, competitors with the nexobrid market share, detailed nexobrid market segments, market trends, and opportunities, and any further data you may need to thrive in the nexobrid industry. This nexobrid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to the growing demand for faster and more effective burn healing solutions, increasing government initiatives for burn care, enhanced accessibility to advanced medical treatments, expansion of healthcare facilities in low- and middle-income countries, growing awareness of the benefits of enzymatic debridement. Major trends in the forecast period include growth in the adoption of advanced wound care products, rising preference for minimally invasive treatments, adoption of AI-driven technologies in burn treatment, integration of regenerative medicine in burn recovery, and collaborative partnerships between governments and healthcare providers.

The rising prevalence of burn injuries is expected to drive the growth of the Nexobrid market. Burn injuries involve physical damage to the skin or other tissues, resulting in tissue destruction, pain, and impaired function. Occupations in industries such as construction, manufacturing, and healthcare pose higher burn injury risks due to exposure to open flames, hot surfaces, and hazardous chemicals. Nexobrid supports burn recovery by efficiently removing eschar from burn wounds, accelerating healing, and reducing the need for surgery, ultimately improving patient outcomes. For instance, in October 2023, the World Health Organization reported that around 180,000 deaths occur each year due to burns, with most occurring in low- and middle-income countries. As a result, the increasing prevalence of burn injuries is expected to drive Nexobrid market growth.

The development of advanced eschar removal drug products is a key trend in the Nexobrid market. These drugs are designed to break down dead tissue formed over burns or wounds, helping to facilitate healing and prevent infections. They support burn care by promoting tissue regeneration and may reduce the need for surgical debridement. In December 2022, MediWound Ltd., an Israel-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved NexoBrid (anacaulase-bcdb) for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns. This treatment features a unique proteolytic enzyme formulation that effectively removes burn eschar in four hours while preserving healthy tissue. NexoBrid offers a non-surgical, quick, and efficient alternative for burn treatment, and it has been approved in over 43 countries, including the United States. It is also supported by the Biomedical Advanced Research and Development Authority (BARDA) to enhance burn care and improve emergency preparedness.

In December 2022, Bharat Serums and Vaccines (BSV) Limited, an India-based biopharmaceutical company, partnered with MediWound Ltd. to expand burn care in India by improving access to NexoBrid. The partnership focuses on enhancing burn management, especially for women and security personnel, to address critical gaps in burn care and improve patient outcomes across the country. MediWound Ltd., based in Israel, is the manufacturer of NexoBrid.

The key company operating in the nexobrid market is MediWound Ltd.

North America was the largest region in the nexobrid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nexobrid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nexobrid market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Nexobrid is a topical enzymatic debridement agent designed for the treatment of severe burns. It selectively removes eschar while preserving healthy tissue, accelerating wound healing, and reducing the need for surgical procedures. This advanced formulation promotes better recovery outcomes and offers a non-invasive solution for burn care.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main formulations of Nexobrid are topical gel, spray, and ointment. The topical gel formulation is intended for direct application to the skin, efficiently delivering active ingredients to the affected area to promote healing. It is used in several clinical indications, such as burn care, chronic wound care, and trauma care. Nexobrid is distributed through various channels, including hospitals, ambulatory surgical centers (ASCs), retail pharmacies, and online pharmacies, and is used by a wide range of end users, including adults, pediatric patients, and the elderly.

The nexobrid market consists of sales of cream, liquid solution, and powder. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.